2016
DOI: 10.1177/0271678x15613798
|View full text |Cite
|
Sign up to set email alerts
|

Hypoxic preconditioning enhances neural stem cell transplantation therapy after intracerebral hemorrhage in mice

Abstract: Previous studies have shown that intraparenchymal transplantation of neural stem cells ameliorates neurological deficits in animals with intracerebral hemorrhage. However, hemoglobin in the host brain environment causes massive grafted cell death and reduces the effectiveness of this approach. Several studies have shown that preconditioning induced by sublethal hypoxia can markedly improve the tolerance of treated subjects to more severe insults. Therefore, we investigated whether hypoxic preconditioning enhan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

4
61
2

Year Published

2016
2016
2022
2022

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 48 publications
(67 citation statements)
references
References 29 publications
4
61
2
Order By: Relevance
“…Compared to control SCs, HIF-1 levels were increased by 5.9 ± 0.2 fold in VP16-HIF SCs. This is within the physiological increase in HIF-1 achieved with hypoxia treatment in other cell types [e.g., stem cells: (Theus et al, 2008;Wakai et al, 2016); bone marrow stromal cells (BMSCs; Theus et al, 2008)], where HIF-1 increases by 2-to 6.5-fold. It is, however, less than the 8-14-fold increase achievable following pharmacological treatment of SCs with the HIF stabilizer, deferoxamine Thus, retroviral expression of a non-degradable form of HIF-1 fused to the VP16transactivation domain elevated HIF-1 levels in SCs to the physiological levels, and was sufficient to elevate the expression of HIF's transcriptional targets.…”
Section: Expression Of Vp16-hif-1 Insupporting
confidence: 51%
“…Compared to control SCs, HIF-1 levels were increased by 5.9 ± 0.2 fold in VP16-HIF SCs. This is within the physiological increase in HIF-1 achieved with hypoxia treatment in other cell types [e.g., stem cells: (Theus et al, 2008;Wakai et al, 2016); bone marrow stromal cells (BMSCs; Theus et al, 2008)], where HIF-1 increases by 2-to 6.5-fold. It is, however, less than the 8-14-fold increase achievable following pharmacological treatment of SCs with the HIF stabilizer, deferoxamine Thus, retroviral expression of a non-degradable form of HIF-1 fused to the VP16transactivation domain elevated HIF-1 levels in SCs to the physiological levels, and was sufficient to elevate the expression of HIF's transcriptional targets.…”
Section: Expression Of Vp16-hif-1 Insupporting
confidence: 51%
“…In addition, after ICH, hemoglobin can cause the death of a large number of transplanted NSCs. Hypoxic preconditioning can increase the expression of VEGF secreted by the NSCs and allow adaptation to the toxic effects of hemoglobin around the hematoma . In the experimental model of a subcortical stroke with WMI, ADMSCs could facilitate the reconstruction of WM fiber tracts and alleviate functional defects …”
Section: Repair or Recovery Mechanism And Strategymentioning
confidence: 99%
“…Hypoxic preconditioning can increase the expression of VEGF secreted by the NSCs and allow adaptation to the toxic effects of hemoglobin around the hematoma. 107 In the experimental model of a subcortical stroke with WMI, ADMSCs could facilitate the reconstruction of WM fiber tracts and alleviate functional defects. 97,108 The use of induced pluripotent stem cells (iPS) is the current focus of attention, because these cells can be tailored to patients for self-use in order to avoid immune rejection, ethical constraints, and tissue donation.…”
Section: Stem Cell Transplantationmentioning
confidence: 99%
“…NSCs can also differentiate into non-neuronal progeny (oligodendrocytes, astrocytes) known to promote homeostasis and support regenerating host axons [31]. Indeed, NSCs can also elicit protection or regeneration of perilesional tissues and circuitries [31,33]. In the past ten years, several preclinical studies focusing on the use of stem cells in ALS transgenic animal models have shown promising results [26,27,31,[34][35][36][37].…”
Section: Neural Stem Cells and Motor Neuron Diseases: Cell Transplantmentioning
confidence: 99%
“…In another study, Wakai and colleagues further demonstrated that mild hypoxia (5% O2 for 24 h) also promotes NSC proliferation and resilience to transplantation by upregulating phospho-Akt (pAkt) expression via HIF-1α and subsequent expression of VEGF [33]. Akt is well known to contribute to self-renewal and differentiation in NSCs.…”
Section: Hypoxic Preconditioningmentioning
confidence: 99%